T1	Participants 905 950	14,916 men initially free of diagnosed cancer
T2	Participants 966 1224	1,066 men with incident prostate cancer (including 496 with aggressive disease, defined as stage C or D, Gleason 7-10, metastatic, and fatal prostate cancer) and 1,618 cancer-free, age- and smoking-matched control participants in the Physicians' Health Study
T3	Participants 2757 2804	men with plasma 25(OH)D levels above the median
